Cargando…
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice
Tyrosine kinase inhibitors are validated therapeutic agents against EGFR-mutated non-small cell lung cancer (NSCLC). However, the associated critical side effects of these agents are inevitable, demanding more specific and efficient targeting agents. Recently, we have developed and reported a non-co...
Autores principales: | Bhat, Zahid Rafiq, Kumar, Manvendra, Sharma, Nisha, Yadav, Umesh Prasad, Singh, Tashvinder, Joshi, Gaurav, Pujala, Brahmam, Raja, Mohd, Chatterjee, Joydeep, Tikoo, Kulbhushan, Singh, Sandeep, Kumar, Raj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457798/ https://www.ncbi.nlm.nih.gov/pubmed/36080307 http://dx.doi.org/10.3390/molecules27175540 |
Ejemplares similares
-
Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment
por: Kumar, Manvendra, et al.
Publicado: (2021) -
MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation
por: Surapaneni, Sunil Kumar, et al.
Publicado: (2020) -
Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches
por: Goel, Kapil Kumar, et al.
Publicado: (2023) -
Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats
por: Tikoo, Kulbhushan, et al.
Publicado: (2009) -
Reliable Establishment of Human Sarcoma Xenografts in the Nude Rat
por: Tinkey, Peggy T., et al.
Publicado: (1999)